The presence of vitamin D receptors in small intestine muscle cells may lead one to think that vitamin D may act locally, infl uencing intracellular calcium concentration and contributing to the contraction-relaxation regulation of the intestinal smooth muscle cells. This study investigates the potential eff ects of vitamin D and calcium on intestinal motility using an in vitro test. ) was added aft er at least 3 hours, it evoked evident and persistent contractions for 60-90 minutes. The contractions were at about 40 % of the peak produced by acetylcholine. Thus, simultaneous intake of vitamin D and calcium might be a useful co-adjuvant in intestinal atony therapy aimed to stimulate normal gut motility in humans. These fi ndings imply that supplemental vitamin D may be important in all cases where calcium has to be prescribed. Health consequences of vitamin D defi ciency are important; recent studies confi rm that vitamin D defi ciency is widespread in children and elderly people (3, 4). Vitamin D
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Keywords
Two major signal transduction pathways activated by 1a,25(OH) 2 D 3 in target cells have been identifi ed: the so-called genomic pathway, where the nuclear receptors play a major role, and the non-genomic signal transduction pathway. In order to ensure full biological activity of 1a,25(OH) 2 D 3 both pathways need to be activated. The non-genomic pathway is faster than that induced following changes in gene expression. It induces rapid changes in intracellular calcium concentrations, alterations in membrane phospholipid metabolism and it activates several signalling transduction pathways (8) .
Biological eff ects induced by the active form of 1a,25(OH) 2 D 3 are mediated by the vitamin D receptor (VDR), also known as the NR1I1 receptor. This receptor belongs to the superfamily of the nuclear receptor (NR), which includes receptors for steroid hormones, retinoids and thyroid hormones (9) .
The presence of the receptor outside the classical target tissues, even in the small intestine muscle cells, may imply that vitamin D acts locally, infl uencing the intracellular calcium concentration and participating in contraction-relaxation regulation of the intestinal smooth muscle cell.
The aim of this study is to investigate the potential eff ects of vitamin D and calcium on intestinal motility using an in vitro test.
EXPERIMENTAL

Chemicals and reagents
The following reagents were used: NaCl, USP grade (Research Organic, Inc., USA), KCl (Carlo Erba Reagenti s.r.l., Italy), CaCl 2 ´ 2H 2 O (Merck, Germany), NaHCO 3 , ACS reagent (Research Organic), MgCl 2 ´ 6H 2 O (Merck), NaH 2 PO 4 ´ H 2 O (Merck), D(+) glucose (Merck), acetylcholine chloride (TCI Europe, Belgium) and 1a,25(OH) 2 D 3, 99 % TLC (Sigma-Aldrich Inc., USA).
).
Instruments
The following instruments were used: Isotonic Transducer no 7006 calibrated to tension of 1 g (Ugo Basile S.p.A, Italy), recording device 'UNIRECORD' for transducer: model 7050 Serial. n. 86503 (Ugo Basile), isolated organ bath, model 4050. Serial No. 00387 -2 Chamber (Ugo Basile S.p.A.), O 2 (95 %) and CO 2 (5 %) tanks (Linde -Arluno, Italy).
Animals, tissue preparation and in vitro tools
The experimental procedure has been described previously (10) . Six male guineapigs weighing 300-400 g (aged 2-3 months, provided by Morini, Italy) were housed in groups with food and water available ad libitum, in a room with controlled temperature (22 ± 1 °C) and under artifi cial 12-h light/12-h dark cycle for at least 4 days before use. The ileum was excised and kept in Tyrode's solution. Each segment, 2-3 cm long, was cleaned and set up under 1 g tension in a 10-mL organ bath containing Tyrode's solution, maintained at 37 °C and gassed with 95 % O 2 and 5 % CO 2 . Changes in tension were recorded under isotonic conditions by a transducer connected to a recorder, which was calibrated before each experiment. The preparations were allowed to equilibrate for 30-40 min and were then stimulated two or three times with ACh (10
) to ascertain their responses. Contractile responses recorded by the transducer were expressed as percentage of the ACh maximum response. The same tissue preparations were generally used for several consecutive tests. Aft er each test, the preparations were allowed to rest for 25 min and were washed three times between tests with Tyrode's solution. Each experimental test was performed on tissue preparations coming from at least four animals. A series of in vitro tests was designed to investigate the potential eff ects of 1a,25(OH) 2 D 3 and calcium (CaCl 2 ´ 2H 2 O) on intestinal motility. Acetylcholine chloride served as a reference substance.
The experimental procedure was approved by the University Ethics Committ ee "La Sapienza" concerning the care and use of mammals in experimental practice. ) of the isolated guinea pig ileum strip without pre-treatment with 1a,25(OH) 2 D 3 .
RESULTS AND DISCUSSION
Eff ect of calcium concentration on isolated guinea pig ileum not pre-treated with 1a,25(OH) 2 D 3
Diff erent concentrations of calcium added to the tissues not pre-treated with 1a,25(OH) 2 ) (Fig. 1) . The lack of response to calcium could be due to the inability of this ion to enter the cell, bind the contracting proteins and trigger contraction mechanisms (Fig. 1) .
Eff ect of calcium on the motility of isolated guinea pig ileum pre-treated with 1a,25(OH) 2 D 3
Addition of 1a,25(OH) 2 washed with Tyrode's solution to remove the tested substances. The mean percent contraction was 39.1 ± 4.1 (mean ± SD, six experiments) of peak of acetylcholine contraction (Fig. 2 ).
Experiments were also performed using diff erent calcium concentrations (Ca 2 : 2.0 ´ 10 , contact time more than 3 hours). Calcium-evoked contractions (mean ± SD, six experiments) were 31.1 ± 3.4 for Ca 2 and 37.0 ± 3.4 % for Ca 4 of the recorded acetylcholine contraction peak (Fig. 3) .
The results confi rm the role of vitamin D in guinea pig ileum muscle cell contractility. Calcium infl ux in the smooth muscle cell seems to be favoured in tissues pre-treated with 1a,25(OH) 2 D 3 and it is followed by contractions evoked by its interaction with proteins specifi cally involved in the contraction (11) . Calcium triggers the contraction process; in fact, this happens aft er it is in the cell and its intracellular concentration is enhanced, activating the muscle contraction.
This late eff ect seems to be due to genomic response rather than non-genomic activity on intestinal smooth muscle. Reported data confi rm that vitamin D promotes calcium transfer into the cell (11) . The contracting activity is a function of intracellular calcium concentration. This, in turn, is determined by h omeostatic mechanisms operating within the cells, which act on membrane channels, transporters and ATP dependent pumps. We found that 1a,25(OH) 2 D 3 may be included among these mechanisms and the indirect role of vitamin D on isolated guinea pig ileum contractility was confi rmed in our research because it promoted the response to calcium.
1a,25(OH) 2 D 3 stimulates calcium absorption, increasing permeability at the intestinal level and active transport. In addition, 1a,25(OH) 2 D 3 modifi es the binding between calmodulin and myosin I, a protein found in the intestinal villous (12) . The binding of calmodulin to myosin promotes calcium entrance into the intestinal cells, while transport within the cytoplasm is ensured by calbindin D, whose synthesis is stimulated by calcitriol itself. Calbindin D is a low molecular mass protein; increased synthesis of calbindin D results in extended absorption of calcium. The calbindin calcium binding domain is similar to that of calmodulin (12) .
The relationship between the intracellular calcium level and contraction evoked is due to the action of ACh on muscarinic receptors located in intestinal smooth muscle cells (muscarinic acetylcholine receptor M3) (13) . The binding of ACh to its receptor triggers a G protein with the production of inositol 1,4,5-triphosphate (IP3). The opening of calcium channels in the endoplasmic reticulum increases calcium levels in the cytoplasm. Calcium binds the troponin belonging to the troponin-tropomyosin system. This complex causes the actin to bind to the myosin fi lament which produces the contraction. All these mechanisms could be applied to our results to emphasize the role of the vitamin in the contraction process.
CONCLUSIONS
Calcium added to isolated guinea pig ileum not pre-treated with 1α,25(OH) 2 D 3 showed no response, probably because the calcium membrane transporters were scarcely expressed or the calcium channels were inactivated and the ion was not able to enter the cells. However, when 1α,25(OH) 2 D 3 was added, followed aft er at least 3 hours by calcium, the response to this ion was evident. 1a,25(OH) 2 D 3 can increase the synthesis of the calcium channel in the cell. In addition, other preliminary results, which are not shown, indicated a potential cholinergic modulation. The main strength of our study was to show that vitamin D has an indirect role in the mechanism of contraction. However, further studies are needed to clarify the role of the receptors involved in the mechanism of action of vitamin D. The current results suggest that supplemental vitamin D and calcium may be useful co-adjuvants in intestinal atony therapy, stimulating normal intestinal motility.
